These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 14684381)
1. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Tashiro M; Samuelson LC; Liddle RA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G784-90. PubMed ID: 14684381 [TBL] [Abstract][Full Text] [Related]
2. Calcineurin-dependent and calcineurin-independent signal transduction pathways activated as part of pancreatic growth. Tashiro M; Dabrowski A; Guo L; Sans MD; Williams JA Pancreas; 2006 Apr; 32(3):314-20. PubMed ID: 16628088 [TBL] [Abstract][Full Text] [Related]
3. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats. Jia D; Taguchi M; Otsuki M Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700 [TBL] [Abstract][Full Text] [Related]
4. Induction of early response genes in trypsin inhibitor-induced pancreatic growth. Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753 [TBL] [Abstract][Full Text] [Related]
5. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade. Varga G; Kisfalvi K; Pelosini I; D'Amato M; Scarpignato C Br J Pharmacol; 1998 Jun; 124(3):435-40. PubMed ID: 9647465 [TBL] [Abstract][Full Text] [Related]
6. Regulator of calcineurin 1 controls growth plasticity of adult pancreas. Gurda GT; Crozier SJ; Ji B; Ernst SA; Logsdon CD; Rothermel BA; Williams JA Gastroenterology; 2010 Aug; 139(2):609-19, 619.e1-6. PubMed ID: 20438729 [TBL] [Abstract][Full Text] [Related]
7. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice. Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881 [TBL] [Abstract][Full Text] [Related]
8. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice. Crozier SJ; Sans MD; Lang CH; D'Alecy LG; Ernst SA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1148-57. PubMed ID: 18356533 [TBL] [Abstract][Full Text] [Related]
9. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats. Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885 [TBL] [Abstract][Full Text] [Related]
10. Infusion of FK506, a specific inhibitor of calcineurin, induces potent tau hyperphosphorylation in mouse brain. Luo J; Ma J; Yu DY; Bu F; Zhang W; Tu LH; Wei Q Brain Res Bull; 2008 Jul; 76(5):464-8. PubMed ID: 18534252 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function. Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055 [TBL] [Abstract][Full Text] [Related]
12. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371 [TBL] [Abstract][Full Text] [Related]
13. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway. Merten KE; Jiang Y; Feng W; Kang YJ J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266 [TBL] [Abstract][Full Text] [Related]
14. Effect of hypergastrinemia and blockade of gastrin-receptors on pancreatic growth in the mouse. Niederau C; Niederau M; Klonowski H; Lüthen R; Ferrell LD Hepatogastroenterology; 1995; 42(4):423-31. PubMed ID: 8586382 [TBL] [Abstract][Full Text] [Related]
15. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats. Harada E; Syuto B Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962 [TBL] [Abstract][Full Text] [Related]
16. Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice. Sato N; Suzuki S; Kanai S; Ohta M; Jimi A; Noda T; Takiguchi S; Funakoshi A; Miyasaka K Jpn J Pharmacol; 2002 Jul; 89(3):290-5. PubMed ID: 12184735 [TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo. Gurda GT; Guo L; Lee SH; Molkentin JD; Williams JA Mol Biol Cell; 2008 Jan; 19(1):198-206. PubMed ID: 17978097 [TBL] [Abstract][Full Text] [Related]
18. The short term satiety peptide cholecystokinin reduces meal size and prolongs intermeal interval. Lateef DM; Washington MC; Sayegh AI Peptides; 2011 Jun; 32(6):1289-95. PubMed ID: 21453733 [TBL] [Abstract][Full Text] [Related]
19. Hormonal control of pancreatic growth. Mainz DL; Black O; Webster PD J Clin Invest; 1973 Sep; 52(9):2300-4. PubMed ID: 4727460 [TBL] [Abstract][Full Text] [Related]
20. Water and enzyme secretion are tightly coupled in pancreatic secretion stimulated by food or CCK-58 but not by CCK-8. Yamamoto M; Reeve JR; Keire DA; Green GM Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G866-79. PubMed ID: 15550556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]